April 6, 2009 - SenoRx said that two peer-reviewed journal articles summarizing clinical findings related to its Contura Multi-Lumen Balloon (MLB) Catheter are pending publication.
These and other studies support the company’s belief that a patient treated with Contura MLB receives a more targeted dose of radiation, while minimizing radiation to healthy tissue such as
the skin and ribs. As a result, more patients are being treated with Contura MLB who previously were not candidates for accelerated partial breast radiation therapy. One article was published in Brachytherapy and a second has been accepted for publication in The American Surgeon:
"Initial Radiation Experience Evaluating Early Tolerance and Toxicities in Patients Undergoing Accelerated Partial Breast Irradiation Using the Contura Multi-Lumen Balloon (MLB) Breast Brachytherapy Catheter. The authors were Brown, S.; McLaughlin, M.; Pope. K.; Haile, K.; Whitaker T.; Hughes, L.; and Israel, P. -- presented at San Antonio Breast Cancer Symposium (SABCS), December 2008, and in press in Brachytherapy, February 2009.
"Initial Surgical Experience Evaluating Early Tolerance and Toxicities in Patients Undergoing Accelerated Partial Breast Irradiation Using the Contura Multi-Lumen Balloon (MLB) Breast Brachytherapy Catheter.” The authors were : Israel, P.; Robbins, A.; Shroff, P.; Haile, K.; and Pope, K. -- presented at Society of Surgical Oncology (SSO), March 2009, and accepted for publication in The American Surgeon.
Since the beginning of 2009, six additional abstracts have been or are scheduled for presentation at major industry meeting.
For more information: www.senorx.com
May 14, 2024 
